ARCHIVES

Arzerra Promising For Heavily Pre-Treated CLL Patients

This article is from The Cancer Letter archive.

Vol. 31 No. 12 | December 26, 2008

Download PDF Visit The Full Archive

Related Articles

FDA Approval Of Two Generic Versions Of Taxol Likely To End BMS Exclusivity.

September 29, 2000

NCAB Opposes Line Item for Centers

May 23, 1980

Groups Push for CMS Coverage for LDCT Lung Screening

October 3, 2014

Funding opportunities listed.

April 16, 2004

More Aggressive Prevention, Detection Could Save Lives, Cancer Policy Board Says

March 28, 2003

NIH Begins Process Of Extramural Program “Reinvention”

July 22, 1994